Australia In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 - 2009/09/30 - Global Markets Direct - Market Research

Report title: Australia In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

from Global Markets Direct - Market Research
174 page report published Sep 30, 2009

Price $2,500.00 available for immediate download

Report Overview

Table of Contents

Search Inside

About Global Markets Direct - Market...

SummaryThis report is an essential source for in-depth information and data relating to Australia In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in AustraliaScope- The report provides information on the Australian in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments. - Total revenues, end users- Market shares of all the key competitors. - Key pipeline products that are set to shape the market, broken down by sector. - Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.- Key mergers and acquisitions, partnerships, private equity investments and IPOs. - Customer, hospitals and physicians data.Reasons to buy- Gain a strong understanding of the in vitro diagnostics devices market in Australia.- Evaluate and compare the attractiveness of the market in the country. - Identify growth segments and opportunities in each industry sector within the country.- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.- Analyze the competitiveness of the market in the country and identify hotspots. - Develop strategies based on the latest product, brand, expansion and research and development news in the country. - Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Source:

Global Markets Direct

Document ID:

GMDME1050ICR

Country:

Australia

Industry:

Medical Devices & Diagnostics

Free Sample:

Click Here to Download

Format:

PDF

Title	Starting Page	Number of Pages
Sections
1 Table of Contents	2	15
1.1 List of Tables	11	4
1.2 List of Figures	15	2
2 Introduction	17	1
2.1 What Is This Report About?	17	1
3 Definitions of Markets Covered in This Report	18	8
3.1 In Vitro Diagnostics	18	1
3.2 Clinical Chemistry	18	1
3.2.1 Clinical Chemistry Rapid Tests & POC	18	1
3.2.2 Clinical Chemisty Analyzers	18	1
3.2.2.1 Automated Clinical Chemistry Analyzers	18	1
3.2.2.2 Semi-Automated Clinical Chemistry Analyzers	18	1
3.2.3 Electrolyte Chemistry Reagents	18	1
3.2.4 Enzyme Chemistry Reagents	19	1
3.2.5 Metabolite Chemistry Reagents	19	1
3.2.6 Urine Analysis	19	1
3.2.6.1 Urine Analyzer Reagents	19	1
3.2.6.2 Urine Analyzers	19	1
3.3 Genetic Testing	19	1
3.3.1 Acquired Gene or Chromosome Alterations	19	1
3.3.2 Inborn Gene or Chromosome Alterations	19	1
3.3.3 Other Genetic Tests	19	1
3.4 Haematology	19	1
3.4.1 Haematology Analyzers	19	1
3.4.2 Haematology Cell Counters	20	1
3.4.2.1 Differential Counters	20	1
3.4.2.2 Hemoglobinometers	20	1
3.4.3 Haematology Rapid Tests	20	1
3.4.3.1 Haemostasis Rapid Tests (Home Monitoring)	20	1
3.4.3.2 Rapid Haematology Tests (Point-Of-Care/Near Patient)	20	1
3.4.4 Haematology Reagents	20	1
3.4.4.1 Haematology Analyzer Reagents	20	1
3.4.4.2 Slide Stainers	20	1
3.4.5 Haemostasis	20	1
3.4.5.1 Coagulation Analyzers	20	1
3.4.5.2 Coagulation Factors	20	1
3.4.5.3 General Coagulation Tests	20	1
3.4.5.4 Platelet Factors	21	1
3.4.5.5 Special Coagulation Tests	21	1
3.4.6 Immunohaematology	21	1
3.4.6.1 ABO Typing	21	1
3.4.6.2 Antibody Detection	21	1
3.4.6.3 Rhesus Typing	21	1
3.5 Histology And Cytology	21	1
3.5.1 Cytology	21	1
3.5.1.1 Flow Cytometers	21	1
3.5.2 Histology	21	1
3.5.2.1 Monoclonal Antibodies	21	1
3.5.2.2 Tissue Typing Reagents	21	1
3.6 Immuno Chemistry	22	1
3.6.1 Disease Specific Immunochemistry	22	1
3.6.1.1 Auto-Immune Diseases	22	1
3.6.1.2 Cardiac Markers	22	1
3.6.1.3 Rheumatoid - Inflammatory Diseases Markers	22	1
3.6.1.4 Tumor markers	22	1
3.6.2 Drug Related Testing	22	1
3.6.2.1 Drugs of Abuse / Toxicology	22	1
3.6.2.2 Therapeutic Drug Monitoring	22	1
3.6.3 Endocrinology Tests	23	1
3.6.3.1 Fertility or Pregnancy Hormones	23	1
3.6.3.2 Individual and Specified Hormones	23	1
3.6.3.3 Thyroid Function Hormones	23	1
3.6.4 Immunochemistry Analyzers	23	1
3.6.4.1 Chemiluminescence Analyzers	23	1
3.6.4.2 ELISA Instruments	23	1
3.6.4.3 Immunofluorescence Analyzers	23	1
3.6.4.4 Radioimmunoassay Analyzers	23	1
3.6.5 Immunochemistry Rapid Tests	23	1
3.6.6 Organ Function Assays	23	1
3.6.7 Specific Proteins	24	1
3.7 Infectious Immunology	24	1
3.7.1 Bacteriology	24	1
3.7.2 Hepatitis Viruses	24	1
3.7.3 Other Virology	24	1
3.7.4 Retroviruses	24	1
3.8 Microbiology Culture	24	1
3.8.1 Bacterial Identification & Susceptibility Testing	24	1
3.8.2 Blood Culture	24	1
3.8.3 Immunological Culture Identification	24	1
3.8.4 Microbiology Analyzers	24	1
3.8.4.1 Automated Microbiology Analyzers	24	1
3.8.4.2 Semi-Automated Microbiology Analyzers	25	1
3.8.5 Mycobacteria Culture	25	1
3.8.6 Mycology Culture	25	1
3.8.7 Parasitology Culture	25	1
4 Healthcare Sector Review	26	10
4.1 Healthcare Expenditure	26	4
4.2 Healthcare Infrastructure	30	4
4.3 Healthcare Policy	34	2
5 Regulation System	36	19
5.1 Medical Equipment Approval Process	36	1
5.1.1 Classification	36	7
5.1.2 Registration and Conformity Assessment	43	2
5.2 Advertising	45	1
5.3 Labeling and Packaging	46	1
5.4 Post-market Surveillance	47	1
5.5 Registration Fee	47	8
6 Pricing and Reimbursement	55	1
7 Distribution Structure	56	1
8 In Vitro Diagnostics In Australia	57	7
8.1 In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015	57	6
8.2 In Vitro Diagnostics, Australia, Company Share (2007-2008)	63	1
9 Clinical Chemistry In Australia	64	10
9.1 Clinical Chemistry Overall Revenue (2000-2015)	64	4
9.1.1 Clinical Chemistry Analyzers Revenue (2000-2015)	68	2
9.1.2 Urine Analysis Revenue (2000-2015)	70	2
9.2 Clinical Chemistry Distribution Share (2007-2008)	72	1
9.3 Clinical Chemistry, Australia, Company Share (2007-2008)	73	1
10 Genetic Testing In Australia	74	4
10.1 Genetic Testing Overall Revenue (2000-2015)	74	2
10.2 Genetic Testing Distribution Share (2007-2008)	76	1
10.3 Genetic Testing, Australia, Company Share (2007-2008)	77	1
11 Haematology In Australia	78	18
11.1 Haematology Overall Revenue (2000-2015)	78	4
11.1.1 Haematology Reagents Revenue (2000-2015)	82	2
11.1.2 Immunohaematology Revenue (2000-2015)	84	2
11.1.3 Haemostasis revenue (2000-2015)	86	4
11.1.4 Haematology Rapid Tests Revenue (2000-2015)	90	2
11.1.5 Haematology Cell Counters Revenue (2000-2015)	92	2
11.2 Haematology Distribution Share (2007-2008)	94	1
11.3 Haematology, Australia, Company Share (2007-2008)	95	1
12 Histology And Cytology In Australia	96	6
12.1 Histology And Cytology Overall Revenue (2000-2015)	96	2
12.1.1 Histology Revenue (2000-2015)	98	2
12.2 Histology And Cytology Distribution Share (2007-2008)	100	1
12.3 Histology And Cytology, Australia, Company Share (2007-2008)	101	1
13 Immuno Chemistry In Australia	102	17
13.1 Immuno Chemistry Overall Revenue (2000-2015)	102	4
13.1.1 Disease Specific Immunochemistry Revenue (2000-2015)	106	2
13.1.2 Drug Related Testing Revenue (2000-2015)	108	2
13.1.3 Endocrinology Tests Revenue (2000-2015)	110	2
13.1.4 Immunochemistry Analyzers Revenue (2000-2015)	112	4
13.2 Immuno Chemistry Distribution Share (2007-2008)	116	1
13.3 Immuno Chemistry, Australia, Company Share (2007-2008)	117	2
14 Infectious Immunology In Australia	119	7
14.1 Infectious Immunology Overall Revenue (2000-2015)	119	4
14.2 Infectious Immunology Distribution Share (2007-2008)	123	1
14.3 Infectious Immunology, Australia, Company Share (2007-2008)	124	2
15 Microbiology Culture In Australia	126	8
15.1 Microbiology Culture Overall Revenue (2000-2015)	126	4
15.1.1 Microbiology Analyzers Revenue (2000-2015)	130	2
15.2 Microbiology Culture Distribution Share (2007-2008)	132	1
15.3 Microbiology Culture, Australia, Company Share (2007-2008)	133	1
16 Overview of Key Companies in India In Vitro Diagnostics Market	134	29
16.1 F. Hoffmann-La Roche Ltd.	134	1
16.1.1 Company Overview	134	1
16.2 Siemens Healthcare	134	1
16.2.1 Company Overview	134	1
16.3 Sysmex Corporation	135	1
16.3.1 Company Overview	135	1
16.3.2 Sysmex Corporation Pipeline Products	135	1
16.3.2.1 Sysmex Corporation Pipeline Products By Equipment Type	135	1
16.3.2.2 Sysmex Corporation Pipeline Products By Development Stage	135	1
16.3.2.3 Sysmex Corporation Pipeline Products By Therapy Area	135	1
16.3.2.4 Sysmex Corporation Pipeline Products By News Summary	136	1
16.4 Abbott Laboratories	137	1
16.4.1 Company Overview	137	1
16.4.2 Abbott Laboratories Pipeline Products	137	1
16.4.2.1 Abbott Laboratories Pipeline Products By Equipment Type	137	1
16.4.2.2 Abbott Laboratories Pipeline Products By Development Stage	137	1
16.4.2.3 Abbott Laboratories Pipeline Products By Therapy Area	137	1
16.5 Beckman Coulter, Inc.	138	1
16.5.1 Company Overview	138	1
16.5.2 Beckman Coulter, Inc. Pipeline Products	138	1
16.5.2.1 Beckman Coulter, Inc. Pipeline Products By Equipment Type	138	1
16.5.2.2 Beckman Coulter, Inc. Pipeline Products By Development Stage	139	1
16.5.2.3 Beckman Coulter, Inc. Pipeline Products By Therapy Area	140	1
16.5.2.4 Beckman Coulter, Inc. Pipeline Products By News Summary	140	1
16.6 Ortho-Clinical Diagnostics Inc.	141	1
16.6.1 Company Overview	141	1
16.6.2 Ortho-Clinical Diagnostics Inc. Pipeline Products	141	1
16.6.2.1 Ortho-Clinical Diagnostics Inc. Pipeline Products By Equipment Type	141	1
16.6.2.2 Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage	142	1
16.6.2.3 Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area	142	1
16.7 OLYMPUS CORPORATION	143	1
16.7.1 Company Overview	143	1
16.8 Qiagen N.V.	143	1
16.8.1 Company Overview	143	1
16.9 bioMerieux S.A.	144	1
16.9.1 Company Overview	144	1
16.10 Bio-Rad Laboratories, Inc.	144	1
16.10.1 Company Overview	144	1
16.11 Phadia AB	145	1
16.11.1 Company Overview	145	1
16.11.2 Phadia AB Pipeline Products	145	1
16.11.2.1 Phadia AB Pipeline Products By Equipment Type	145	1
16.11.2.2 Phadia AB Pipeline Products By Development Stage	145	1
16.11.2.3 Phadia AB Pipeline Products By Therapy Area	146	1
16.11.2.4 Phadia AB Pipeline Products By News Summary	146	1
16.12 DiaSorin S.p.A	147	1
16.12.1 Company Overview	147	1
16.12.2 DiaSorin S.p.A Pipeline Products	147	1
16.12.2.1 DiaSorin S.p.A Pipeline Products By Equipment Type	147	1
16.12.2.2 DiaSorin S.p.A Pipeline Products By Development Stage	147	1
16.12.2.3 DiaSorin S.p.A Pipeline Products By Therapy Area	147	1
16.13 Becton, Dickinson and Company	148	1
16.13.1 Company Overview	148	1
16.14 Gen-Probe Incorporated	149	1
16.14.1 Company Overview	149	1
16.14.2 Gen-Probe Incorporated Pipeline Products	149	1
16.14.2.1 Gen-Probe Incorporated Pipeline Products By Equipment Type	149	1
16.14.2.2 Gen-Probe Incorporated Pipeline Products By Development Stage	150	1
16.14.2.3 Gen-Probe Incorporated Pipeline Products By Therapy Area	150	1
16.14.2.4 Gen-Probe Incorporated Pipeline Products By Clinical Trials	150	1
16.14.2.5 Gen-Probe Incorporated Pipeline Products By News Summary	151	1
16.15 Inverness Medical Innovations, Inc.	152	1
16.15.1 Company Overview	152	1
16.15.2 Inverness Medical Innovations, Inc. Pipeline Products	152	1
16.15.2.1 Inverness Medical Innovations, Inc. Pipeline Products By Equipment Type	152	1
16.15.2.2 Inverness Medical Innovations, Inc. Pipeline Products By Development Stage	153	1
16.15.2.3 Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area	153	1
16.15.2.4 Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials	153	1
16.15.2.5 Inverness Medical Innovations, Inc. Pipeline Products By News Summary	154	1
16.16 Dade Behring Holdings, Inc.	155	1
16.16.1 Company Overview	155	1
16.17 Ventana Medical Systems, Inc.	155	1
16.17.1 Company Overview	155	1
16.18 Vision BioSystems Ltd	155	1
16.18.1 Company Overview	155	1
16.19 Cellestis Limited	156	1
16.19.1 Company Overview	156	1
16.20 GeneWorks Pty. Ltd.	156	1
16.20.1 Company Overview	156	1
16.21 Astral Scientific Pty Ltd	156	1
16.21.1 Company Overview	156	1
16.22 Enterix Australia Pty Ltd	157	1
16.22.1 Company Overview	157	1
16.23 Cellabs Pty Ltd	157	1
16.23.1 Company Overview	157	1
16.24 Diagnostic Technology	158	1
16.24.1 Company Overview	158	1
16.24.2 Diagnostic Technology Pipeline Products	158	1
16.24.2.1 Diagnostic Technology Pipeline Products By Equipment Type	158	1
16.24.2.2 Diagnostic Technology Pipeline Products By Development Stage	158	1
16.24.2.3 Diagnostic Technology Pipeline Products By Therapy Area	158	1
16.24.2.4 Diagnostic Technology Pipeline Products By Clinical Trials	158	1
16.25 Universal Biosensors, Inc.	159	1
16.25.1 Company Overview	159	1
16.25.2 Universal Biosensors, Inc. Pipeline Products	159	1
16.25.2.1 Universal Biosensors, Inc. Pipeline Products By Equipment Type	159	1
16.25.2.2 Universal Biosensors, Inc. Pipeline Products By Development Stage	159	1
16.25.2.3 Universal Biosensors, Inc. Pipeline Products By Therapy Area	160	1
16.26 Panbio Limited	161	1
16.26.1 Company Overview	161	1
16.26.2 Panbio Limited Pipeline Products	161	1
16.26.2.1 Panbio Limited Pipeline Products By Equipment Type	161	1
16.26.2.2 Panbio Limited Pipeline Products By Development Stage	161	1
16.26.2.3 Panbio Limited Pipeline Products By Therapy Area	162	1
16.26.2.4 Panbio Limited Pipeline Products By News Summary	162	1
17 Financial Deals Landscape	163	5

Enter the keyword(s) which you would like to search for within this document and click "Search"

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Price: $2,500.00

Free Sample

Questions about
this research?

Send page to a friend

Return to
Alacra Company Snapshot

Get FREE Research

Can't Decide?

Purchasing premium research sight unseen can be intimidating. We want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.